Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet by Kang, Young-Rye et al.
23
Anti-obesity and anti-diabetic effects of Yerba Mate
(Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet
Young-Rye Kang
1, Hak-Yong Lee
1, Jung-Hoon Kim
1, Dea-In Moon
1, Min-Young Seo
1, Sang-Hoon Park
1, 
Kwang-Ho Choi
2, Chang-Ryong Kim
2, Sang-Hyun Kim
2, Ji-Hyun Oh
2, Seong-Wan Cho
3,
Sun-Young Kim
4, Min-Gul Kim
4, Soo-Wan Chae
4, Okjin Kim
5*, Hong-Geun Oh
1*
1Huvet Co. Ltd, Iksan, Korea
2GS E&C, Seoul, Korea
3Department of pharmaceutical Engineering, Konyang University, Nonsan, Korea
4Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, Jeonju, Korea
5Center for Animal Resources Development, Wonkwang University, Iksan, Korea
Yerba Mate, derived from the leaves of the tree, Ilex paraguariensis, is widely-used as a tea or as an
ingredient in formulated foods. The aim of the present study was to evaluate the effects of Yerba Mate
extract on weight loss, obesity-related biochemical parameters, and diabetes in high-fat diet-fed mice.To
this end, by using in vivo animal models of dietary-induced obesity, we have made the interesting
observations that Yerba Mate has the ability to decrease the differentiation of pre-adipocytes and to
reduce the accumulation of lipids in adipocytes, both of which contribute to a lower growth rate of
adipose tissue, lower body weight gain, and obesity. Our data from in vivo studies revealed that Yerba
Mate treatment affects food intake, resulting in higher energy expenditure, likely as a result of higher
basal metabolism in Yerba Mate-treated mice. Furthermore, in vivo effects of Yerba Mate on lipid
metabolism included reductions in serum cholesterol, serum triglycerides, and glucose concentrations in
mice that were fed a high fat diet. In conclusion, Yerba Mate can potentially be used to treat obesity and
diabetes.
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Yerba Mate (Ilex paraguariensis), consumed as an
herbal tea beverage, is one of the most widely-used
plants worldwide. Yerba Mate is commercially packed in
individual tea bags or as Mate tea concentrates for use
as an ingredient in dietary supplement industries [1-4].
The major difference between green tea and Mate tea
production is the drying method. Green tea is dried
primarily through fast, high-temperature air drying, but
Mate tea is dried very slowly and often using wood
smoke. This imparts very different flavor characteristics
and contributes to changes in chemical makeup and
physical appearance. Numerous active phytochemicals
have been identified in Yerba Mate, including polyphenols
(chlorogenic acid), xanthines (caffeine and theobromine),
purine alkaloids (caffeic acid, 3,4-dicaffeoylquinic acid,
and 3,5-dicaffeoylquinic acid), flavonoids (quercetin,
kaempferol, and rutin), amino acids, minerals (phosphorous,
iron, and calcium), and vitamins (C, B1, and B2) [5-8].
Recently published data have highlighted the beneficial
effects of Ilex paraguariensis, which include antioxidant
activity [9-11] and inhibition of atherosclerosis [12-14].
In particular, studies have also suggested its potential in
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the management of obesity [15-17].
Obesity is a growing problem, resulting in significant
morbidity and mortality due to weight-related diseases,
as well as a reduced quality of life. The defect in energy
balance that causes obesity and visceral adiposity is a
serious problem that predisposes individuals to
complications, such as atherosclerosis, hepatic steatosis,
and type 2 diabetes [18]. The increasing incidence of
obesity suggests that this epidemic will only worsen in
the future [19]. Animal models are useful tools to
evaluate the efficacy of potential compounds in the
prevention and treatment of obesity. It has been reported
that rodents fed a high-fat diet are excellent models of
obesity, where the dietary environment is a major
contributor [20]. Obesity has become a very important
issue in Korean society. Yerba Mate, a potential
treatment for obesity, is rarely used in Korea.
The aim of the present study was to evaluate the
effects of Yerba Mate extract on weight loss, obesity-
related biochemical parameters, and diabetes in high-fat
diet-fed mice, as natural products can show different
characteristics and pharmacological differences
depending on their growing district. 
Materials and Methods
Sample preparation
Yerba Mate was collected in Argentina. The collected
1 kg Yerba Mate was thoroughly washed in water, and
the sample was extracted 3 times with 10 L distilled
water at 100
oC for 2 hours, so extract powder of 200
gram was obtained. The extract was dissolved in purified
water prior to oral administration. Yerba Mate extract or
vehicle (purified water) was administered by intragastric
gavage, in order to guarantee total ingestion. The
animals were treated for 4 weeks and received either 0.5,
1, or 2 g/kg instant Yerba Mate/kg body weight.
Animals and diets
Male, five-week old C57BL/6J mice (18-23 g), free of
specific pathogens, were purchased from SAMTAKO
BIO Korea (Osan, Korea). The experiments were performed
in accordance with the principles and approval from
Ethics Committee of the Wonkwang University, Iksan,
Korea (Approval No. WKU11-001). All animals, which
were maintained in a temperature-controlled room
(temperature 22±2
oC, humidity 50±5%) on a 12 h light/
dark cycle, were acclimatized to the laboratory environment
while housed in individual cages for 1 week before the
experiment. Obesity was induced by a 60% fat calorie
diet, and mice were randomly divided into 5 groups after
the first 6 weeks on the high-fat diet (AIN-93G, cat.,
#101556; Research Diet, Inc., NJ, USA), as follows:
regular diet group (Normal diet), high-fat diet group
(HFD, control group), HFD+0.5 g/kg Yerba Mate (HFD
+Mate 0.5), HFD+1 g/kg Yerba Mate (HFD+Mate 1.0),
and HFD+2 g/kg Yerba Mate (HFD+Mate 2.0). For oral
administration, the drugs were diluted in purified water
and administered once per day for 4 weeks. At the end
of the experiment, mice were deeply anaesthetized (1:1
xylazine:ketamine), and blood samples were collected
and stored at −80
oC until they were analyzed.
Measurements of glucose, triglyceride, cholesterol,
and leptin levels
After 4 weeks of treatment, blood samples were collected
and centrifuged at 3,000 rpm for 15 min at 4
oC, and
serum glucose, triglyceride (TG), total cholesterol (T-
CHO), high-density lipoprotein (HDL), low-density
lipoprotein (LDL), and leptin levels were measured
according to the kit manufacturer’s instruction.
Measurements of body, organ, and fat weight
Body weight was measured once a week during the
feeding period. Internal organs were dissected and
weighed. Fat tissue samples also were stored at −80
oC
until they were analyzed.
Histological analysis
Histological analysis was conducted following a previous
reported method [21]. Briefly, the dissected tissues were
fixed in 10% neutral buffered formalin for histological
analysis and embedded in paraffin. The paraffin-
embedded sections were cut at a thickness of 4 µm and
stained with hematoxylin and eosin. adipocyte sizes
were measured in randomly chosen microscopic areas
from independent animals using an Olympus microscope
system, and average adipocyte size was calculated by
dividing the chosen microscopic area by total adipocyte
cell number in the area.
Statistical analysis
All data were expressed as mean±standard error (SE),
and differences between groups were analyzed using
one-way ANOVA (Duncan’s multiple-range test). Each
value was the mean of at least 3 separate experiments inEffects of Ilex paraguariensis on obesity and diabetes 25
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each group, and mean values were considered significantly
different when P values were less than 0.05.
Results
Body weights, food intake, and blood glucose levels
We measured the body weights and food intake of the
mice once a week after 4 weeks of receiving a Normal
diet or HFD with or without Yerba Mate treatment.
Compared to HFD mice, Yerba Mate decreased food and
water intake in C57BL/6J mice on the HFD (Figure 1).
The body weight of the HFD group was increased. Body
weight gains were significantly less in Yerba Mate-
treated HFD groups. Furthermore, blood glucose was
also lowered after treatment with Yerba Mate (Figure 2).
Effect of Yerba Mate on absolute fat tissue weight and
organ weight in C57BL/6J mice fed HFD
The weights of organs, such as liver, spleen, heart,
kidneys, and testes, were increased in HFD mice compared
to the HFD group (Figure 3). As shown in Figure 4 and
Table 1, the weight of epididymal, retroperitoneal and
peri-renal fat tissue in HFD group was increased
compared to the normal group, and the fat tissue weight
of HFD mice treated with Yerba Mate was much smaller
than the HFD group. Additionally, the size of adipocytes
Figure 1. Effects of Yerba Mate on change of food (A) and water (B) intake in a mouse obesity model induced by a high-fat diet.
a, b, c, dValues in the row with different superscript letters are significantly different,
 P<0.05. Data are shown as mean±SE (n=10).
Figure 2. Effects of Yerba Mate on changes in body weight (A) and blood glucose (B) in a mouse obesity model induced by a high-
fat diet. 
a, b, c, dValues in the row with different superscript letters are significantly different,
 P<0.05. Data are shown as mean±SE
(n=10).
Figure 3. Effects of Yerba Mate on organ weight in a mouse
obesity induced model by a high-fat diet. 
a, b, cValues in the row
with different superscript letters are significantly different,
P<0.05. Data are shown as mean±SE (n=10).26 Young-Rye Kang et al.
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from Yerba Mate-treated HFD animals was smaller
compared with adipocytes from control HFD animals.
Effect of Yerba Mate on histological hepatic changes in
C57BL/6J mice fed HFD
Hepatic steatosis was increased in the HFD group
compared to the Normal diet, and it was decreased by
Yerba Mate administration, dependent on concentration,
but we were unable to observe the hepatocyte balloon
and inflammatory cell disposition in the all groups
(Figure 5). Histological analysis showed that the
adipocyte size changed less in the group receiving Yerba
Mate (Figure 6).
Effect of Yerba Mate on fat weight, triglyceride,
cholesterol, and leptin concentration
To determine if Yerba Mate has an anti-obesity effect
in HFD-fed mice, we measured fat weight, TG, T-CHO,
HDL-CHO, LDL-CHO, and leptin concentration after 4
weeks during Yerba Mate administration. The Yerba
Mate-treated group had significantly lower serum TG
and total cholesterol concentrations than did the HFD
Table 1. Effects of Yerba Mate on percent change in organ weight relative to body weight in an obesity model induced by a high-fat
diet
Normal HFD HFD+Mate 0.5 HFD+Mate 1.0 HFD+Mate 2.0
Liver 3.54±0.04
a 2.37±0.09
d 2.56±0.05
c 2.77±0.06
b 2.84±0.05
b
Spleen 0.21±0.02
a 0.15±0.00
c 000.18±0.01
abc 00.19±0.01
ab 00.16±0.00
bc
Heart 0.44±0.01
a 0.34±0.02
b 0.41±0.02
a 00.39±0.01
ab 0.97±0.03
a
Kidneys 1.04±0.03
a 0.80±0.03
c 0.91±0.02
b 0.95±0.02
b 00.97±0.03
ab
Testes 0.72±0.02
a 0.53±0.02
b 0.63±0.03
a 0.66±0.04
a 0.63±0.02
a
Epididymal Fat 1.54±0.08
d 5.50±0.36
a 4.07±0.24
b 3.13±0.31
c 2.82±0.44
c
Retroperitoneal Fat 0.36±0.03
d 1.75±0.08
a 1.31±0.09
b 10.7±0.12
b 0.70±0.12
c
Peri-renal Fat 0.23±0.02
c 0.81±0.07
a 0.45±0.03
b 0.33±0.04
c 0.28±0.04
c
a, b, c, dValues in the row with different superscript letters are significantly different,
 P<0.05. Data are shown as mean±SE (n=10).
Figure 4. Effects of Yerba Mate on absolute fat weight in a
mouse obesity model induced by a high-fat diet. EPI: Epididymal,
RP: Retroperitoneal fat, RN: Peri-renal fat. 
a, b, c, d, eValues in the
row with different superscript letters are significantly different,
P<0.05. Data are shown as mean±SE (n=10).
Figure 5. Effects of Yerba Mate on histological hepatic steatosis in a mouse obesity model induced by a high-fat diet. A: Normal, B:
HFD. C: HFD+Mate 0.5, D: HFD+Mate 1.0, E: HFD+Mate 2.0. (400× magnification). Arrow indicates steatosis (n=10).Effects of Ilex paraguariensis on obesity and diabetes 27
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group. The leptin levels of the Yerba Mate-treated
groups were also markedly reduced compared to those
of the HFD group (Table 2 and Figure 7).
Discussion
Mate has central nervous system-stimulant properties
that are attributed to its methylxanthine alkaloids, such
as caffeine [22], and it is known to contain compounds
with antioxidant properties, such as phenolic acids and
caffeoylquinic acid derivatives, which are the most
abundant compounds in the leaves [23,24]. Other reported
effects, including hepatoprotective, choleretic, diuretic,
hypocholesterolemic, anti-rheumatic, antithrombotic,
anti-inflammatory, anti-obesity, and cardioprotective
effects, may partially be explained its popularity [23,25].
Figure 6. Effects of Yerba Mate on histological adipocyte size in a mouse obesity model induced by a high-fat diet. A: Normal, B:
HFD. C: HFD+Mate 0.5, D: HFD+Mate 1.0, E: HFD+Mate 2.0, F: quantitative analysis (400× magnification). 
a, b, c, dValues in the row
with different superscript letters are significantly different,
 P<0.05. Data are shown as mean±SE (n=6).
Table 2. Effects of Yerba Mate on changes in blood parameters in an obesity model induced by a high-fat diet
Total Cholesterol (mg/dL)  TG (mg/dL)  LDL (mg/dL)  HDL (mg/dL)
Normal 081.67±2.75
c 22.11±1.24 2.99±0.22
c 50.11±1.54
HFD 157.00±3.55
a 022.8±2.32 4.80±0.24
b 70.20±1.84
HFD+Mate 0.5
0151.11±3.87
ab 21.78±1.71 4.90±0.42
b 71.62±1.59
HFD+Mate 1.0 142.63±3.36
b 17.38±0.80 5.54±0.55
b 70.83±1.14
HFD+Mate 2.0 140.22±5.24
b 25.89±3.04 6.89±0.40
a 71.73±2.03
TG: triglyceride, LDL: low density lipoprotein, HDL: high density lipoprotein. 
a, b, cValues in the row with different superscript letters are
significantly different,
 P<0.05. Data are shown as mean±SE (n=9).28 Young-Rye Kang et al.
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Yerba Mate may have benefits over other weight-loss
herbal medicines and supplements, the use of which has
been clinically linked to adverse events [26].
Because type 2 diabetes is a chronic and progressive
disorder, pharmacotherapy will need to address drug-
related side effects over longer time periods. Obesity is
a well-recognized risk factor for type 2 diabetes, when
combined with other known risk factors. It has been an
important therapeutic goal to reduce the risk of type 2
diabetes through weight management. To this end, by
using in vivo animal models of dietary-induced obesity,
we have made the interesting observations that Yerba
Mate has the ability to decrease the differentiation of pre-
adipocytes and reduce accumulation of lipids in adipocytes,
both of which contribute to lessened growth of adipose
tissue, lower body weight gain, and decreased obesity.
Our data from in vivo studies revealed that Yerba Mate
treatment affects food intake and results in higher energy
expenditure, likely from a higher basal metabolism in
Yerba Mate-treated mice. Furthermore, in vivo effects of
Yerba Mate on lipid metabolism included a significant
reduction in serum cholesterol and reduced trends in
serum triglyceride and glucose concentrations in mice
fed HFD. These factors are the major players in
metabolic syndrome and associated disorders.
Yerba Mate has been reported to have various biological
activities, which are mainly attributed to its high polyphenol
content [24]. Chlorogenic acid, the main polyphenol in
Yerba Mate, is thought to modulate the activity of
glucose-6-phosphatase, which is involved in glucose
metabolism [27], and to reduce the risk of cardiovascular
disease by decreasing the oxidation of LDL and
cholesterol [28]. In this sense, our results are in accordance
with previous studies that have shown that Ilex
paraguariensis treatment improves glucose tolerance in
obese animals [14,29]. In addition to chlorogenic acid,
methylxanthines are also thought to account for some of
the pharmacological effects of Yerba Mate [30].
Saponins, another important class of compounds found
in Yerba Mate, have been reported to interfere with
cholesterol metabolism [31]. Thus, the effects of Yerba
Mate on cholesterol levels could be partially attributed to
its saponin content. The data presented in this study
suggest that Yerba Mate extract may act synergistically
to suppress body weight gain and visceral fat accumulation
and to decrease the serum levels of cholesterol,
triglycerides, and glucose. Adipose tissue is an endocrine
organ, which has a fundamental role in metabolism and
homeostasis regulation. The production and secretion of
an excess or insufficient amount of adipokines greatly
influence insulin sensitivity, glucose metabolism,
inflammation, and atherosclerosis and may provide a
molecular link between increased adiposity and the
development of diabetes mellitus, metabolic syndromes,
and cardiovascular diseases [32]. In the present study,
the level of leptin in serum was directly affected by a
high-fat diet. Additionally, treatment with Yerba Mate
extract recovered the concentration of leptin.
In conclusion, this study found that Yerba Mate extract
has potent anti-obesity activity in vivo. Additionally, we
observed that Yerba Mate treatment has a modulatory
effect on glucose levels related to obesity.
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